Prof. Dr. AŞKIN ATEŞ

Yayın Ağı

Makaleler 153

1. Interstitial Pneumonia with Autoimmune Features from the Rheumatologists’ Perspective; Single Center Experience

USLU E., Sahin D., Ilbay A., Yilmaz R., Gaydan A., Govec Giynas N., et al.

Diagnostics , cilt.16, sa.2, 2026 (SCI-Expanded, Scopus)

2. Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis

Casares-Marfil D., Gribbons K. B., Saruhan-Direskeneli G., Kaymaz-Tahra S., Quinn K. A., ALİBAZ ÖNER F., et al.

Journal of Autoimmunity , cilt.157, 2025 (SCI-Expanded, Scopus)

3. Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS Experience

Kocaayan H., Ediboglu E. D., Yıldırım T. D., Ulusoy B. O., Ogut T. S., Firlatan B., et al.

International journal of rheumatic diseases , cilt.28, sa.12, 2025 (SCI-Expanded, Scopus)

4. Deep Learning Performance in Analyzing Nailfold Videocapillaroscopy Images in Systemic Sclerosis

Yayla M. E., Aydın A., Kılıçaslan M., Kalkan M., Güzel M. S., Shikhaliyeva A., et al.

DIAGNOSTICS , cilt.15, sa.22, 2025 (SCI-Expanded, Scopus)

5. Ultrasonographic evaluation of hand and wrist joints in patients with systemic sclerosis

Ermancık Z., Yayla M. E., İlbay A., Göveç Gıynaş N., Sezer S., Uslu E., et al.

Journal of Scleroderma and Related Disorders , cilt.10, sa.3, ss.510-517, 2025 (ESCI, Scopus)

6. Malignancy-associated risk factors in patients with systemic sclerosis

Baysal S., Şahin D., Sezer S., Yayla M. E., Uslu E., Ateş A., et al.

Journal of Scleroderma and Related Disorders , cilt.10, sa.3, ss.518-522, 2025 (ESCI, Scopus)

7. Impact of age at disease onset on clinical manifestations and prognosis in systemic lupus erythematosus Sistemik lupus eritematozusta hastalık başlangıç yaşının klinik belirtiler ve prognoz üzerindeki etkisi

Şahin D., Bulat B., Uslu E., Göveç Gıynaş N., Turhan G., Kader M., et al.

Journal of Turkish Society For Rheumatology , cilt.17, sa.2, ss.60-67, 2025 (Scopus, TRDizin)

8. Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease

Bulut Gökten D., Tezcan M. E., YAĞIZ B., ERDEN A., KİMYON G., YAŞAR BİLGE N. Ş., et al.

International Journal of Rheumatic Diseases , cilt.28, sa.5, 2025 (SCI-Expanded, Scopus)

9. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience

Durak Ediboglu E., KALYONCU U., Solmaz D., YAŞAR BİLGE N. Ş., Yılmaz S., Bes C., et al.

Archives of Rheumatology , cilt.40, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus, TRDizin)

10. Evaluation of performance of the Still Activity Score for assessment of Adult-onset Still's Disease: Comparative study with Systemic Feature Score and Modified Pouchot-Activity Score Evaluación del desempeño de la puntuación de actividad de Still en la valoración de la enfermedad de Still de inicio en la adultez: un estudio comparativo con la puntuación de las características sistémicas y la puntuación de la actividad modificada de Pouchot

Uslu E., Yayla M. E., Şahin Eroğlu D., Atmaca-Haktaniyan B., Göveç Gıynaş N., Yılmaz R., et al.

Reumatologia Clinica , cilt.21, sa.2, 2025 (ESCI, Scopus)

11. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

Uzun G. S., Gököz Ö., Öğüt B., Heper A., Güreşçi S., Kardaş R. C., et al.

Rheumatology International , cilt.44, sa.11, ss.2547-2554, 2024 (SCI-Expanded, Scopus)

12. Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational Study

Moroni L., Gallina G., Lanzillotta M., Maggioni S., Benanti G., Cariddi A., et al.

ARTHRITIS & RHEUMATOLOGY , ss.5054-5057, 2024 (SCI-Expanded, Scopus)

13. Rheumatoid Arthritis-Related Lung Disease and Its Association With Mortality

Şahin Eroğlu D., Çolaklar A., Baysal S., Torgutalp M., Baygül A., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.30, sa.5, ss.177-182, 2024 (SCI-Expanded, Scopus)

14. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.

Clinical and Experimental Rheumatology , cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus)

15. The Performance of 2023 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) Antiphospholipid Syndrome Classification Criteria in a Real-World Rheumatology Department

USTA A., YAYLA M. E., USLU E., SEZER S., US E., ATEŞ A., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.16, sa.1, 2024 (SCI-Expanded, Scopus)

16. Are there differences in the clinical and laboratory features of patients with seronegative primary Sjögren's syndrome?

Yayla M. E., Aksoy R., Uslu E., Karaman Z., Yılmaz R., Ilbay A., et al.

Turkish journal of medical sciences , cilt.54, sa.5, ss.956-962, 2024 (SCI-Expanded, Scopus, TRDizin)

17. A comparison of adult and juvenile Behcet patients and a look at clinical trends: Retrospective data from a Turkish follow-up cohort study

BOYVAT A., ÖKTEM A., YILDIZHAN İ., ATEŞ A., YALÇINDAĞ F. N., Koksoy C., et al.

DERMATOLOGY , sa.6, ss.958-965, 2023 (SCI-Expanded, Scopus)

18. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up study

YAĞIZ B., LERMİ N., COŞKUN N., DALKILIÇ H. E., KİRAZ S., ERDEN A., et al.

RHEUMATOLOGY , sa.12, ss.3962-3967, 2023 (SCI-Expanded, Scopus)

19. Aksiyel spondiloartrtit hastalarında secukinumab deneyimi: Tek merkez 3 yıllık gerçek yaşam verileri

USLU YURTERİ E., ŞAHİN EROĞLU D., AYDEMİR GÜLÖKSÜZ E. G., İLBAY A., TURGAY T. M., KINIKLI G., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.3, ss.113-119, 2023 (Scopus, TRDizin)

20. Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre

Uslu Yurteri E., Şahin Eroğlu D., Aydemir Gülöksüz E. G., İlbay A., Turgay T. M., Kınıklı G., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.3, ss.113-119, 2023 (TRDizin)

21. Investigation of COVID-19 Vaccination and Disease Status in Behçet’s Patients

Yılmaz R., Sezer S., İlbay A., Göveç Gıynaş N., Aydemir Gülöksüz E. G., Gaydan A., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.76, sa.3, ss.206-212, 2023 (Hakemli Dergi)

22. Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database

Ersözlü E. D., EKİCİ M., COŞKUN B. N., Badak S. Ö., BİLGİN E., KALYONCU U., et al.

Archives of Rheumatology , cilt.38, sa.3, ss.347-357, 2023 (SCI-Expanded, Scopus, TRDizin)

23. Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance

Aydemir Guloksuz E. G., Sezer S., YAYLA M. E., Sahin Eroglu D., USLU YURTERİ E., Kelesoglu Dincer A. B., et al.

Journal of Clinical Rheumatology , cilt.29, sa.4, ss.177-182, 2023 (SCI-Expanded, Scopus)

24. The factors predicting development of serious infections in ANCA-associated vasculitis

USLU YURTERİ E., Sezer S., Torgutalp M., YAYLA M. E., Eroglu D. S., Okatan I. E., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.40, sa.2, 2023 (SCI-Expanded, Scopus)

25. Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?

Atagündüz P., Kiraz S., Akar S., Küçükşahin O., Erden A., Aksoy A., et al.

Clinical and experimental rheumatology , cilt.41, sa.3, ss.620-627, 2023 (SCI-Expanded, Scopus)

26. Two birds with one stone: a Bruton's tyrosine kinase inhibitor in a patient with rheumatoid arthritis and 17p+chronic lymphocytic leukaemia

Sahin Eroglu D., DALVA K., Azap A., Kutlay N., Ates A., Yuksel M.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.52, sa.6, ss.703-704, 2023 (SCI-Expanded, Scopus)

27. Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data

KALYONCU U., BİLGİN E., Erden A., Satış H., TUFAN A., Tekgöz E., et al.

Clinical and experimental rheumatology , cilt.40, sa.11, ss.2071-2077, 2022 (SCI-Expanded, Scopus)

28. Does IL33/Sst2 Pathway Play a Role in the Pathogenesis of Familial Mediterranean Fever?

Keleşoğlu Dinçer A. B., Sezer S., Aydemir Gülöksüz E. G., Yayla M. E., Torgutalp M., Uslu Yurteri E., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.75, sa.3, ss.406-412, 2022 (TRDizin)

29. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

Ilgen U., KARADAĞ Ö., EMMUNGİL H., KÜÇÜKŞAHİN O., KOCA S. S., Erden A., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.10, ss.1797-1806, 2022 (SCI-Expanded, Scopus)

30. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database

Kanitez N. A., KİRAZ S., Dalkilic E., Kimyon G., Mercan R., KARADAĞ Ö., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , sa.4, ss.206-211, 2022 (ESCI, TRDizin)

31. Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., Inanc N., KOCA S. S., et al.

RHEUMATOLOGY ADVANCES IN PRACTICE , cilt.6, sa.3, 2022 (ESCI, Scopus)

32. Neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio and mean platelet volume can be an indicator of subclinical inflammation in patients with Familial Mediterranean Fever

Dincer A. B. K., Guloksuz E. G. A., Sezer S., YILMAZ R., TURGAY T. M., ATEŞ A., et al.

EGYPTIAN RHEUMATOLOGIST , cilt.44, sa.3, ss.215-218, 2022 (ESCI, Scopus)

33. Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey

Yayla M. E., ŞAHİN EROĞLU D., USLU YURTERİ E., Dincer A. B. K., Sezer S., AYDEMİR GÜLÖKSÜZ E. G., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1457-1463, 2022 (SCI-Expanded, Scopus)

34. Prognostic factors for relapse and poor outcome in neuro-Behcet's syndrome: results from a clinical long-term follow-up of a single centre

ŞAHİN EROĞLU D., Torgutalp M., YÜCESAN C., Sezer S., Yayla M. E., BOYVAT A., et al.

JOURNAL OF NEUROLOGY , cilt.269, sa.4, ss.2046-2054, 2022 (SCI-Expanded, Scopus)

35. Analysis of vascular involvement in 460 patients with Behc , et's syndrome: Clinical characteristics and associated factors

Torgutalp M., Şahin Eroğlu D., Sezer S., Yayla M. E., Karataş G., Uslu Yurteri E., et al.

JOINT BONE SPINE , cilt.89, sa.2, 2022 (SCI-Expanded, Scopus)

36. Interstitial Lung Disease in Systemic Sclerosis: A Single-center Retrospective Analysis

Yayla M. E., Balci G., USLU YURTERİ E., ŞAHİN EROĞLU D., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., et al.

CURRENT RHEUMATOLOGY REVIEWS , cilt.18, sa.2, ss.150-156, 2022 (ESCI, Scopus)

37. Can Subclinical Atherosclerosis Be Assessed More Precisely in Behcet Syndrome Patients by Using a Particular Cutoff Value for Carotid Intima Media Thickness?

Uslu Yurteri E., Üstüner E., Torgutalp M., Yayla M. E., Okatan I. E., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.28, sa.1, 2022 (SCI-Expanded, Scopus)

38. Causes of severe infections in patients with systemic sclerosis and associated factors

YAYLA M. E., USLU YURTERİ E., USLU YURTERİ E., Sahin D., Sezer S., Dincer A. B. K., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.6, ss.1881-1888, 2022 (SCI-Expanded, Scopus, TRDizin)

39. Patients characteristics in Behcet's Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases

Torgutalp M., Eroglu D. S., Sezer S., Yayla M. E., Karatas G., Ozel E. M., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.51, sa.1, ss.50-58, 2022 (SCI-Expanded, Scopus)

40. RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Eroglu D. S., Colaklar A., Baysal S., Torgutalp M., Baygul A., YAYLA M. E., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.39, sa.3, 2022 (SCI-Expanded, Scopus)

41. Clinical characteristics of pulmonary artery involvement in patients with Behcet's syndrome: single-centre experience of 61 patients

ŞAHİN EROĞLU D., Torgutalp M., Baysal S., ÇOLAKLAR A., Sezer S., Yayla M. E., et al.

CLINICAL RHEUMATOLOGY , cilt.40, sa.10, ss.4127-4134, 2021 (SCI-Expanded, Scopus)

42. Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study

Eroglu D. S., Colaklar A., Baysal S., USLU YURTERİ E., Baygul A., Sezer S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.590-592, 2021 (SCI-Expanded, Scopus)

43. The Importance of Lower Extremity Vein Wall Thickness in Patients with Behcet's Syndrome

Kocabay H. E., YAYLA M. E., ÜSTÜNER E., Yurteri E. U., Guloksuz E. A., Sezer S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.3915-3917, 2021 (SCI-Expanded, Scopus)

44. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results

Bilge N. S. Y., Kalyoncu U., ATAGÜNDÜZ M. P., Dalkilic E., Pehlivan Y., Kucuksahin O., et al.

American Journal of Ophthalmology , cilt.228, ss.58-64, 2021 (SCI-Expanded, Scopus)

45. Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data

Kimyon G., Kalyoncu U., Kiraz S., Bes C., Coskun N., Yagiz B., et al.

Clinical and Experimental Rheumatology , cilt.39, sa.4, ss.852-858, 2021 (SCI-Expanded, Scopus)

46. Serum-Beta-2-Mikroglobulin-level bei Patienten mit rheumatoider Arthritis und ihre Beziehung zur Krankheitsaktivitat: Kann es als Krankheitsaktivitatsmarker verwendet werden?

Dincer A. B. K., Torgutalp M., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., USLU YURTERİ E., et al.

AKTUELLE RHEUMATOLOGIE , cilt.46, sa.3, ss.297-304, 2021 (SCI-Expanded, Scopus)

47. Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels

Torgutalp M., Yayla M. E., Eroglu D. S., Dincer A. B. K., Yurteri E., Okatan I. E., et al.

Mediterranean Journal of Rheumatology , cilt.32, sa.1, ss.56-65, 2021 (Scopus) Sürdürülebilir Kalkınma

48. Share Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.

TORĞUTALP M., YAYLA M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., USLU YURTERİ E., OKATAN İ. E., et al.

MEDITERRANEAN JOURNAL OF RHEUMATOLOGY (MJR) , cilt.32, sa.1, ss.56-65, 2021 (Scopus)

49. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

Ortiz-Fernandez L., Saruhan-Direskeneli G., ALİBAZ ÖNER F., Kaymaz-Tahra S., Coit P., Kong X., et al.

American Journal of Human Genetics , cilt.108, sa.1, ss.84-99, 2021 (SCI-Expanded, Scopus)

50. Clinical Features of Patients with Antiphospholipid Syndrome and Differences of Patients with Recurrent Thrombosis, A Single Center Retrospective Study

YAYLA M. E., yüksel m., ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., KELEŞOĞLU DİNÇER A. B., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.74, sa.1, ss.52-59, 2021 (TRDizin)

51. Complete blood count derived haematological parameters do not correlate with disease activity in patients with radiographic axial spondyloarthritis

ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., YAYLA M. E., ÖZEL M., TURGAY T. M., et al.

Ulusal Romatoloji Dergisi , cilt.13, 2021 (TRDizin)

52. Response to Secukinumab Treatment in Active Psoriatic Arthritis Patients- Single Center Experience

KELEŞOĞLU DİNÇER A. B., SEZER S., AYDEMİR GÜLÖKSÜZ E. G., YAYLA M. E., TORĞUTALP M., USLU YURTERİ E., et al.

Journal of Ankara University Faculty of Medicine , cilt.74, 2021 (TRDizin)

53. High mobility group box-1 levels may be associated with disease activity of Behcet's disease

Donmez Guler D., Kelesoglu Dincer A. B., KARAHAN Z. C., Guler H. S., Yayla M. E., Sezer S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2690-2697, 2021 (SCI-Expanded, Scopus, TRDizin)

54. Are There Any Clues to Predict Bamboo Spine in Axial Spondyloarthritis?

ATAGÜNDÜZ M. P., KİRAZ S., AKAR S., KÜÇÜKŞAHİN O., Erden A., COŞKUN N., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.72, 2020 (SCI-Expanded, Scopus)

55. Early onset primary Sjogren syndrome, clinical and laboratory characteristics

Yayla M. E., Karaman Z., Torgutalp M., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., et al.

CLINICAL RHEUMATOLOGY , cilt.39, sa.9, ss.2689-2696, 2020 (SCI-Expanded, Scopus)

56. Romatoid artrit hastalarında serum gebelikle ilişkiliplazma protein-A düzeylerinin incelenmesi

Torgutalp M., DOĞAN Ö., Yayla M. E., Eroğlu D. Ş., Dinçer A. B. K., SEZER S., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.2, ss.45-50, 2020 (Hakemli Dergi)

57. Evaluation of serum pregnancy associated plasma protein-A levels in patients with rheumatoid arthritis

TORĞUTALP M., DOĞAN Ö., Yayla M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., SEZER S., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.2, ss.45-50, 2020 (Scopus, TRDizin)

58. Tofacitinib in Patients with Rheumatoid Arthritis: Single-center Experience Rheumatoid Arthritis and Tofacitinib

Yayla M. E., ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.20-25, 2020 (TRDizin)

59. Tofacitinib in Patients with Rheumatoid Arthritis: Single-center Experience Rheumatoid Arthritis and Tofacitinib

Yayla M. E., Şahin Eroğlu D., Torgutalp M., Sezer S., Keleşoğlu Dinçer A. B., Aydemir Gülöksüz E. G., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.20-25, 2020 (TRDizin)

60. Idiopathic retroperitoneal fibrosis: A single center case series of 17 patients

TORĞUTALP M., DOĞAN Ö., Yayla M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., SEZER S., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.1, ss.22-26, 2020 (TRDizin)

61. Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features

Yayla M. E., Torgutalp M., Okatan I. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., Dincer A. B. K., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.26, sa.3, ss.83-86, 2020 (SCI-Expanded, Scopus)

62. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis

Yayla M. E., Ilgen U., Okatan I. E., UsluYurteri E., Torgutalp M., Kelesoglu Dincer A. B., et al.

CLINICAL RHEUMATOLOGY , cilt.39, sa.1, ss.77-83, 2020 (SCI-Expanded, Scopus)

63. Tuberculin Skin Test and Quantiferon (R)-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid Arthritis

Ilgen U., Turan S., EMMUNGİL H., Sari A., Erden A., KILIÇ L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

64. Clinical significance of aortic stiffness, carotid intima-media thickness and serum osteoprotegerin level in rheumatoid arthritis patients

Ozisler C., ATEŞ A., Karaaslan Y., Elalmis O. U., Parlak I. S., Dortbas F., et al.

EGYPTIAN RHEUMATOLOGIST , cilt.41, sa.2, ss.111-115, 2019 (ESCI, Scopus) Sürdürülebilir Kalkınma

65. Turkish Society for Rheumatology recommendations for biosimilar drugs

DALKILIÇ H. E., ATEŞ A., HAZNEDAROĞLU Ş., KESKİN G., KOCA S. S., Özbalkan Z., et al.

Ulusal Romatoloji Dergisi , cilt.10, sa.2, ss.85-87, 2018 (TRDizin)

66. Factors That May be Associated with Uveitis in Patients with Spondyloarthritis

KAŞİFOĞLU T., YAŞAR BİLGE N. Ş., KİRAZ S., Ertenli I., KÜÇÜKŞAHİN O., DALKILIÇ H. E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

67. Interim Analysis of Baseline Characteristics and Preferences of Administration Route of Rheumatoid Arthritis Patients Who Are Bio-Naive or Switched between Advanced RA Treatments; A Multicenter, Prospective, Observational Study

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., Inanc N., KOCA S. S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

68. Vascular Involvement in Behcet's Syndrome May be Associated with Subclinical Atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., Torgutalp M., Yayla M. E., Okatan I. E., Dincer A. B. K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

69. Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis

Kimyon G., KİRAZ S., Ertenli I., KÜÇÜKŞAHİN O., DALKILIÇ H. E., Bes C., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

70. Corticosteroid Utilization before and after Initiation of Biologic Dmards between Patients with Rheumatoid Arthritis

Yagiz B., COŞKUN B. N., KİRAZ S., Ertenli I., KÜÇÜKŞAHİN O., DALKILIÇ H. E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

71. PREDICTORS OF FEAR OF MOVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

KINIKLI G. İ., GÜNEY DENİZ H., KARAHAN S., ATEŞ A., Turgay M., KINIKLI G.

TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-FIZYOTERAPI REHABILITASYON , cilt.29, sa.2, ss.11-17, 2018 (ESCI, TRDizin)

72. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus

Ilgen U., Yayla M. E., Ates A., Okatan I. E., Yurteri E., Torgutalp M., et al.

LUPUS , sa.4, ss.665-669, 2018 (SCI-Expanded, Scopus)

73. **Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis**

Ortiz-Fernandez L., David Carmona F., Lopez-Mejias R., Francisca Gonzalez-Escribano M., Lyons P. A., Morgan A. W., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.4, ss.589-595, 2018 (SCI-Expanded, Scopus)

74. Methodology of a new inflammatory arthritis registry: TReasure

KALYONCU U., Tascilar E. K., ERTENLİ A. İ., DALKILIÇ H. E., Bes C., KÜÇÜKŞAHİN O., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.4, ss.856-861, 2018 (SCI-Expanded, Scopus, TRDizin)

75. TAKAYASU'S ARTERITIS: EXPERIENCE OF A SINGLE TERTIARY CENTER

Dincer A. B. K., Torgutalp M., Guloksuz E. G. A., Yurteri E. U., Yayla M. E., Okatan I. E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.1, 2018 (SCI-Expanded, Scopus)

76. Predictors of fear of movement in patients with rheumatoid arthritis

KINIKLI G. İ., Deniz H. G., KARAHAN S., ATEŞ A., Turgay M., KINIKLI G.

Turkish Journal of Physiotherapy and Rehabilitation , cilt.29, sa.2, ss.11-17, 2018 (Scopus, TRDizin)

77. A GOOD MIMIC: PMR - IS PMR THE ACCURATE DIAGNOSIS? A SINGLE-CENTER STUDY

Aydin T., Isikoglu B. D., Koc O., Dincer A. B. K., Torgutalp M., Yayla M. E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.1, 2018 (SCI-Expanded, Scopus)

78. The role of IL-33 in Behçet’xxs disease

KELEŞOĞLU DİNÇER A. B., Yayla M. E., ATEŞ A.

RAED Dergisi , cilt.9, sa.1-2, ss.32-34, 2017 (Hakemsiz Dergi)

79. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever

KÜÇÜKŞAHİN O., YILDIZGÖREN M. T., Ilgen U., Ates A., Kinikli G., Turgay M., et al.

MODERN RHEUMATOLOGY , sa.2, ss.350-355, 2017 (SCI-Expanded, Scopus)

80. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

David Carmona F., Coit P., SARUHAN DİRESKENELİ G., Hernandez-Rodriguez J., Cid M. C., Solans R., et al.

SCIENTIFIC REPORTS , cilt.7, 2017 (SCI-Expanded, Scopus)

81. Effect of DMARD Therapies on NSAID Intake, Quality of Life, and Physical Functioning in Patients with Ankylosing Spondylitis

KINIKLI G., KINIKLI G. İ., KARAHAN S., Yuksek A., ATEŞ A., Turgay M.

ARTHRITIS & RHEUMATOLOGY , 2016 (SCI-Expanded, Scopus)

82. İDİYOPATİK RETROPERİTONEAL FİBROZİS 7 OLGULUK VAKA SERİSİ

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., YAYALA M. E., OKATAN İ. E., KINIKLI G., TURGAY T. M., et al.

RAED DERGİSİ , cilt.8, ss.74, 2016 (TRDizin)

83. PULMONER TUTULUMLU PRİMER SİSTEMİK SKLEROZDA SERUM PROKALSİTONİN DÜZEYİ ENFEKSİYÖZ PULMONER HASTALIKLARDAN AYIRDETTİRİCİ MİDİR

OKATAN İ. E., KINIKLI S., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.

RAED DERGİSİ , cilt.8, ss.75-76, 2016 (TRDizin)

84. VASKÜLER BEHÇET HASTALARININ KARAKTERİSTİK ÖZELLİKLERİ

ATEŞ A., OKATAN İ. E., TORĞUTALP M., USLU YURTERİ E., BAŞAKSU Ö., YALÇINER M., et al.

RAED DERGİSİ , cilt.8, ss.156, 2016 (TRDizin)

85. BEHÇET HASTALIĞI TANISI İLE TAKİBEDİLEN HASTALARIN ULUSLARARASI BEHÇET HASTALIĞI TANI KRİTERLERİNE GÖRE YENİDEN DEĞERLENDİRİLMESİ

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., YAYLA M. E., ATEŞ A., TURGAY T. M., et al.

RAED DERGİSİ , cilt.8, ss.55, 2016 (TRDizin)

86. RAYNAUD FENOMENİ İLE BAŞVURAN HASTALAR İLE BAĞ DOKU HASTALIĞI OLAN HASTALARIN KAPİLLOROSKOPİK VE LABORATUVAR ÖZELLİKLERİNİN KARŞILAŞTIRILMASI

TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.

RAED DERGİSİ , cilt.8, ss.56, 2016 (TRDizin)

87. ANTİFOSFOLİPİD ANTİKOR BİRLİKTELİĞİ OLAN VE OLMAYAN SİSTEMİK LUPUS ERİTEMATOZUSLU HASTALARIN AYIRDEDİCİ KLİNİK VE LABORATUVAR ÖZELLİKLERİ

YAYLA M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.

RAED DERGİSİ , cilt.8, ss.142, 2016 (Hakemli Dergi)

88. ATEŞİN NADİR BİR NEDENİ MEZENTERİK PANNİKÜLİT

KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., TORĞUTALP M., YAYLA M. E., KINIKLI G., TURGAY T. M., et al.

RAED DERGİSİ , cilt.8, ss.106-107, 2016 (TRDizin)

89. Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey

KÜÇÜKŞAHİN O., ATEŞ A., Turkcapar N., TÖRÜNER M., Turgay M., Duman T., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , sa.4, ss.317-324, 2016 (SCI-Expanded, Scopus, TRDizin)

90. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study

Oguz E. O., KÜÇÜKŞAHİN O., Turgay M., YILDIZGÖREN M. T., ATEŞ A., Demir N., et al.

CLINICAL RHEUMATOLOGY , sa.3, ss.663-666, 2016 (SCI-Expanded, Scopus)

91. Behcet's: A Disease or a Syndrome? Answer from an Expression Profiling Study

Oguz A. K., Yilmaz S. T., Oygur C. S., Candar T., Sayin I., SERİN KILIÇOĞLU S., et al.

PLOS ONE , cilt.11, sa.2, 2016 (SCI-Expanded, Scopus)

92. Lack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever

KÜÇÜKŞAHİN O., Seker Z., ŞAHİN A., KINIKLI G., TUNCALI T., Turgay M., et al.

ARCHIVES OF RHEUMATOLOGY , sa.2, ss.107-111, 2016 (SCI-Expanded, Scopus, TRDizin)

93. SEXUAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS

Ucar I., KÜÇÜKŞAHİN O., Turgay M., Ates A., Kinikli G., Duzgun N.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1124, 2015 (SCI-Expanded, Scopus)

94. THE ROLE OF SERUM KL-6 GLYCOPROTEIN LEVELS IN LUNG INVOLVEMENT PATIENTS WITH CONNECTIVE TISSUE DISEASES

Oktay E., KÜÇÜKŞAHİN O., Turgay M., Ates A., Demir N., ÖZDEMİR KUMBASAR Ö., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.887-888, 2015 (SCI-Expanded, Scopus)

95. Retro-orbital granuloma associated with granulomatosis with polyangiitis: a series of nine cases

Bitik B., KILIÇ L., KÜÇÜKŞAHİN O., Sahin K., TUFAN A., KARADAĞ Ö., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.35, sa.6, ss.1083-1092, 2015 (SCI-Expanded, Scopus)

96. THE RELATIONSHIP BETWEEN DISEASE ACTIVITY, FUNCTIONAL INDEX, SLEEP QUALITY, ANXIETY, DEPRESSION, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

Ates A., Dortbas F., Karaaslan Y.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.497-498, 2015 (SCI-Expanded, Scopus)

97. Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study

Renauer P. A., Saruhan-Direskeneli G., Coit P., Adler A., AKSU K., KESER G., et al.

Arthritis and Rheumatology , cilt.67, sa.5, ss.1361-1368, 2015 (SCI-Expanded, Scopus)

98. C-type lectin domain family 12, member A: A common denominator in Behçet's syndrome and acute gouty arthritis

Oguz A. K., Yilmaz S., Akar N., ÖZDAĞ SEVGİLİ H., Gurler A., Ates A., et al.

Medical Hypotheses , cilt.85, sa.2, ss.186-191, 2015 (SCI-Expanded, Scopus)

99. THE RELATION BETWEEN DISEASE ACTIVITY, FINDINGS AND MEAN PLATELET VOLUME IN BEHCET'S DISEASE

Uzerk M., KÜÇÜKŞAHİN O., Turgay M., Ozturk B., Turgay B., ATEŞ A., et al.

ACTA MEDICA MEDITERRANEA , cilt.31, sa.6, ss.1233-1239, 2015 (SCI-Expanded, Scopus)

100. BOSENTAN FOR DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: SINGLECENTER EXPERIENCE

KÜÇÜKŞAHİN O., Ates A., Ilgrn U., Ozturk B., Kinikli G., Turgay M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.2, 2014 (SCI-Expanded, Scopus)

101. ERAP-1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and anyklosing spondylitis

KÜÇÜKŞAHİN O., Turkcapar N., Ates A., TÖRÜNER M., Duman T., Cetinkaya H., et al.

JOURNAL OF CROHNS & COLITIS , cilt.8, 2014 (SCI-Expanded, Scopus)

102. Treatment Resistant Severe Digital Ischemia Associated with Antiphospholipid Syndrome in a Male Patient with Systemic Sclerosis

KÜÇÜKŞAHİN O., ATEŞ A., Alexis O., Emre K., TURGAY T. M., KINIKLI G.

Case Reports in Rheumatology , cilt.2014, ss.1-3, 2014 (Hakemli Dergi)